The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Aesthet Surg J
; 41(12): 1423-1438, 2021 11 12.
Article
in En
| MEDLINE
| ID: mdl-33944913
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Blepharoptosis
/
Skin Aging
/
Botulinum Toxins, Type A
/
Neuromuscular Agents
Type of study:
Clinical_trials
Limits:
Adult
/
Humans
Language:
En
Journal:
Aesthet Surg J
Year:
2021
Type:
Article